Skip to main content
Department of Health & Human Services OIG , Department of Justice OIG

Pharmaceutical Manufacturer Assertio Therapeutics, Inc. to Pay $3.6 Million to Resolve Allegations that It Violated the False Claims Act in Connection with Marketing its Fentanyl Product